HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 131 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is 0.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $909,000 | +154.6% | 70,942 | +157.6% | 0.02% | +150.0% |
| Q1 2017 | $357,000 | -42.8% | 27,542 | -56.4% | 0.01% | -33.3% |
| Q4 2016 | $624,000 | +77.8% | 63,184 | +117.7% | 0.02% | +87.5% |
| Q3 2016 | $351,000 | +135.6% | 29,020 | +84.9% | 0.01% | +100.0% |
| Q1 2016 | $149,000 | -18.6% | 15,695 | +48.9% | 0.00% | +33.3% |
| Q4 2015 | $183,000 | -60.7% | 10,539 | -69.6% | 0.00% | -62.5% |
| Q3 2015 | $466,000 | +87.1% | 34,663 | +213.8% | 0.01% | +100.0% |
| Q2 2015 | $249,000 | +4.2% | 11,047 | -58.0% | 0.00% | -20.0% |
| Q3 2014 | $239,000 | -33.1% | 26,282 | -27.3% | 0.01% | -16.7% |
| Q2 2014 | $357,000 | -15.0% | 36,176 | +29.1% | 0.01% | +20.0% |
| Q4 2013 | $420,000 | +63.4% | 28,015 | +20.1% | 0.01% | +66.7% |
| Q3 2013 | $257,000 | – | 23,326 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 1,129,551 | $47,091,000 | 6.38% |
| First Light Asset Management, LLC | 2,011,350 | $83,853,000 | 5.56% |
| TRAN CAPITAL MANAGEMENT, L.P. | 1,353,208 | $56,415,000 | 5.03% |
| SNYDER CAPITAL MANAGEMENT L P | 2,920,860 | $121,771,000 | 3.50% |
| DOHENY ASSET MANAGEMENT /CA | 120,028 | $5,004,000 | 3.39% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 104,945 | $4,375,000 | 2.39% |
| Redwood Investments, LLC | 542,764 | $22,628,000 | 1.99% |
| Kent Lake Capital LLC | 85,000 | $3,544,000 | 1.44% |
| Lisanti Capital Growth, LLC | 263,460 | $10,984,000 | 1.41% |
| Bellevue Group AG | 3,011,966 | $125,569,000 | 1.33% |